ArticleScientific reports2025
Predictive topological modeling of the structure-property relationships in naturally occurring anti-cancer chalcones.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a comprehensive predictive topological modeling framework was employed to investigate the quantitative structure-property relationships (QSPR) of naturally occurring anticancer chalcones. A series of degree-based topological indices, including the first and second Zagreb indices, first and second redefined Zagreb indices, sum-connectivity index, symmetric division index, Randić index, and harmonic index, were computed to represent key molecular structural features. Statistical and regression analyses were performed to correlate these indices with experimentally reported physicochemical properties of chalcones. The study focuses on eight naturally derived anticancer Chalcones, namely, Isoliquiritigenin, Butein, Cardamonin, Sappanchalcone, Licochalcone A, Millepachine, Xanthohumol, and Curcumin-selected based on their structural diversity and well-documented pharmacological potential. Correlations between the computed indices and several physicochemical parameters, such as molecular complexity, molecular weight, molar refractivity, and polarizability, were examined. The study also includes a comprehensive statistical evaluation of the regression models to assess the predictive accuracy, robustness, and reliability of the proposed descriptors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.